Your session is about to expire
← Back to Search
Behavioral Intervention
Intermittent Fasting for Bipolar Disorder
N/A
Recruiting
Led By Sheri L Johnson, PhD
Research Sponsored by University of California, Berkeley
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up post-intervention (10 weeks) and at 1.5 and 3 months follow-ups post-intervention, as compared to baseline
Awards & highlights
No Placebo-Only Group
Summary
"This trial aims to study how following a time-restricted eating plan affects daily rhythms in the body's clock genes, and how this may impact symptoms of mania and depression in individuals with bipolar disorder.
Who is the study for?
This trial is for individuals with bipolar I or II disorder, who speak English and have been on a stable mood-stabilizing medication regimen for at least one month. They should not have had significant weight changes recently, eat over a 12-hour period regularly, and can use a phone camera and web surveys. People with sleep disorders or those doing shift work that disrupts sleep are excluded.
What is being tested?
The study tests if following an 8-week time-restricted eating plan affects the body's natural rhythms and if these changes can improve mania and depression symptoms in people with bipolar disorder. Participants will also track their eating, sleep, mood daily before starting TRE.
What are the potential side effects?
While specific side effects are not detailed here, time-restricted eating may lead to hunger outside of eating windows, potential changes in energy levels during fasting periods, possible headaches or irritability due to adjustments in meal timing.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ post-intervention (10 weeks) and at 1.5 and 3 months follow-ups post-intervention, as compared to baseline
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~post-intervention (10 weeks) and at 1.5 and 3 months follow-ups post-intervention, as compared to baseline
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Depression
Mania
Self-rated Quality of Life (QOL)
Secondary study objectives
Acceptability
Daily emotional lability as assessed using ecological momentary assessment
Depression at follow-up
+4 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Time Restricted Eating (TRE) for 8 weeksExperimental Treatment1 Intervention
Participants will receive an intro to TRE and then throughout 8 weeks they will receive brief online psychoeducation several times per week with optional weekly coaching sessions. TRE involves restricting the window of eating to 10 hours/ day, most typically by avoiding eating in the first 1-2 hours after awakening and in the 2-4 before sleep. Those with an eating window \> 14 hours will be asked to restrict their eating to 12 hours in the first week, then 10 hours in week 2. To select the period, investigators will ask Ss to review baseline logs to consider sleep, eating, family meals and social commitment schedules, and any special energy demands, such as exercise. During the eating window, no restrictions are placed on the type or quantity of food consumed. The investigators will instruct participants to follow their habitual diet within their 10-hour eating window and to aim to consume the same number of calories per day as they did at baseline.
Find a Location
Who is running the clinical trial?
Salk Institute for Biological StudiesOTHER
20 Previous Clinical Trials
1,805 Total Patients Enrolled
1 Trials studying Bipolar Disorder
300 Patients Enrolled for Bipolar Disorder
University College, LondonOTHER
863 Previous Clinical Trials
38,754,625 Total Patients Enrolled
2 Trials studying Bipolar Disorder
344 Patients Enrolled for Bipolar Disorder
University of California, BerkeleyLead Sponsor
187 Previous Clinical Trials
640,826 Total Patients Enrolled
4 Trials studying Bipolar Disorder
655 Patients Enrolled for Bipolar Disorder
Wellcome TrustOTHER
220 Previous Clinical Trials
15,687,589 Total Patients Enrolled
1 Trials studying Bipolar Disorder
300 Patients Enrolled for Bipolar Disorder
Swinburne University of TechnologyOTHER
21 Previous Clinical Trials
7,718 Total Patients Enrolled
2 Trials studying Bipolar Disorder
602 Patients Enrolled for Bipolar Disorder
Deakin UniversityOTHER
33 Previous Clinical Trials
21,267 Total Patients Enrolled
2 Trials studying Bipolar Disorder
602 Patients Enrolled for Bipolar Disorder
University of British ColumbiaOTHER
1,476 Previous Clinical Trials
2,493,530 Total Patients Enrolled
16 Trials studying Bipolar Disorder
1,728 Patients Enrolled for Bipolar Disorder
Sheri L Johnson, PhDPrincipal InvestigatorUniversity of California, Berkeley
1 Previous Clinical Trials
300 Total Patients Enrolled
1 Trials studying Bipolar Disorder
300 Patients Enrolled for Bipolar Disorder